ResearcherThe University of Texas Health Science Center at HoustonNo recent work listed

Lakmini Kumari Senavirathna

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0911-7320; OpenAlex author ID A5021662265. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper

Papers 1

Protein Advanced Glycation End Products and Their Implications in Pancreatic Cancer. Co-author DOI 10.1158/1940-6207.capr-23-0162 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ru Chen · 1 shared paper, 2023 · strength 0.31
- Paper Protein Advanced Glycation End Products and Their Implications in Pancreatic Cancer. DOI 10.1158/1940-6207.capr-23-0162 ↗
Sheng Pan · 1 shared paper, 2023 · strength 0.31
- Paper Protein Advanced Glycation End Products and Their Implications in Pancreatic Cancer. DOI 10.1158/1940-6207.capr-23-0162 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.